Similar cellular responses may presumably occur in RA during joint involvement and the formation of extra-articular lesions, and FAP serves as one of the receptors on the surface of FLSs that may recognize each other with NETs and be a targeted therapeutic surface biomarker for blocking RA progression. Here, FAP is linked to rheumatoid arthritis.